Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03371498Phase 3Terminated
A Phase 3 trial of methylprednisolone in acute respiratory distress syndrome (ARDS), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Dec 2018; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03371498.